Measuring levels of a protein known as suPAR in the blood could be useful for assessing the severity of…
Articles by Marisa Wexler, MS
Argenx is planning to submit an application to the U.S. Food and Drug Administration (FDA) by the end…
A 60-year-old man being treated for multiple myeloma was found to have myasthenia gravis (MG) caused by antibodies…
Achieving minimal disease symptoms six months after thymectomy predicts favorable long-term outcomes in people with myasthenia gravis (MG), a study suggests.
Treatment with rituximab is safe, provides clinical improvements and enables stopping maintenance therapies in patients with late-onset myasthenia gravis…
New guidelines have been published to help patients and physicians manage myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome…
Out-of-pocket expenses for people in China who have myasthenia gravis increased from 2013 to 2015, suggesting that current policies for…
An anti-inflammatory molecule, known as the complement inhibitor zilucoplan, was seen to significantly ease disease severity in generalized myasthenia…
Myasthenia gravis (MG) can occur in very elderly patients, a recent case report highlights. As such, there is a need…
People with myasthenia gravis (MG) are at higher risk of developing serious infections than those without the condition, a recent…